Hot on the heels of our popular Meeting the Brain immersion, LearningLife again joins the University’s Department of Neuroscience, the Udall Center of Excellence for Parkinson's Disease Research, and MnDRIVE Brain Conditions to explore forays into mending the human brain. This immersion offers the opportunity to learn, firsthand, about the University’s groundbreaking research and promising new treatments for a host of brain conditions and diseases.
Following introductory remarks by Dr. Jerrold Vitek, four of the University’s finest neuroscience researchers will highlight their brain-mending discoveries aimed at elucidating and alleviating some of our most devastating brain conditions. Topics include: Identifying and Understanding the Source of Forgetfulness in Alzheimer’s Disease; Lighting the Way to New Epilepsy Treatments; Neurobiology of Drug-induced Brain Changes and Addiction; and Brain-mending in Parkinson’s Disease and Movement Disorders: Past, Present, Future.
Tuition includes breakfast and lunch.
Offered in cooperation with the Department of Neuroscience, the Udall Center
of Excellence for Parkinson's Disease Research, and MnDRIVE Brain Conditions.
Scott Cooper, MD, PhD, Columbia University, is an Assistant Professor of Neurology at the University of Minnesota where he also is a clinical neurologist, co-leader of the clinical core for the Udall Center of Excellence for Parkinson's Disease Research, and a Neuromodulation Scholar for MnDRIVE Brain Conditions. His research focuses on developing neuromodulation therapies for Parkinson's symptoms that resist available treatments.
Esther Krook-Magnuson, PhD, Georgetown University, is an Assistant Professor of Neuroscience at the University of Minnesota where she also is a Neuromodulation Scholar for MnDRIVE Brain Conditions. Her lab works to improve understanding of neuronal networks in health and brain-based disorders, including identifying circuit elements capable of inhibiting seizures in order to improve seizure control while reducing or eliminating side effects through targeted, selective, intervention strategies.
Sylvain Lesné, PhD, Université de Caen, is an Associate Professor of Neuroscience at the University of Minnesota where he also is an Institute for Translational Neuroscience Scholar and the Associate Director of the N. Bud Grossman Center for Memory Research and Care. His research goals are to identify the cause of memory impairment in Alzheimer's disease using cellular and mouse models, and to develop new treatments for the disease.
Mark Thomas, PhD, University of California, Los Angeles, is an Associate Professor of Neuroscience and Psychology at the University of Minnesota, where he also is the Director of MnDRIVE Optogenetics. His research team is working to find a neural “switch” that can turn off relapse behavior in order to help people in recovery from addiction to stay abstinent.
Jerrold Vitek, MD, PhD, University of Minnesota, is a McKnight Professor and Head of the Department of Neurology at the University. He also is Director of the Neuromodulation Research Center, leads the Udall Center of Excellence for Parkinson’s Disease Research, and is a leadership team member of MnDRIVE Brain Conditions. World leaders in neuromodulation and deep-brain stimulation therapies, the research of Vitek and his team dedicated to developing deep-brain stimulation therapies for conditions such as Parkinson’s disease, dystonia, and tremor; this research is often conducted in partnership with Minnesota companies such as Boston Scientific, Medtronic, and St. Jude Medical.